scribed the abundance distribution of artificial life forms (z 0 -2, most commonly) (12) , marine phages (z 0 -1.64 and -1.73) (13, 14) , and plant communities (15) and may arise from a variety of mechanisms (12, 16, 17) . Alternatively, a log-Laplace distribution, which would appear as a power law when measured by DNA reassociation, may arise from an ensemble of lognormals (18, 19) that individually describe the abundance distribution of different functional groups (e.g., denitrifiers, iron reducers, and sulfate reducers).
The zipf and log-Laplace differed mathematically in describing the rare species (Fig. 3) . This difference in the two functions was not apparent in the values of c v 2 as a result of the incompleteness of the curves and the magnitude of the measurement error, which masks small changes in the shape. The ambiguous shape of the distribution for rare species demonstrates that a portion of the community is veiled. Although a reasonable estimate can be obtained of the minimum number of species in the community (including the veiled fraction), additional work is required to obtain a fully accurate description of the entire species-abundance distribution.
Although the shape of the abundance distribution is of fundamental importance, the total diversity is often of greatest interest in environmental assessment and regulatory policy. For each soil, the model-free, zipf, and log-Laplace estimates of S t agreed within a factor of two (Fig. 4) . Given the qualitative and quantitative similarity of these distributions, we averaged the three to obtain an estimate for each soil. Thus, the noncontaminated, low-metal, and high-metal soils respectively contained about 8.3 Â 10 6 , 6.4 Â 10 4 , and 7.9 Â 10 3 species among approximately 10 10 cells Eor 10 g of soil; this represents the quantity of DNA used in the reassociation experiments (11)^. Our estimates of S t were larger by a factor of 4 to 500 than the original estimates of 1.6 Â 10 4 , 6.4 Â 10 3 , and 2.0 Â 10 3 species.
On the basis of our estimates, metal pollution reduced diversity more than 99.9%. Interestingly, total bacterial biomass remained unchanged at about 2 Â 10 9 cells per gram of soil despite metal exposure (8) . Our abundance models were consistent with this observation and indicated that the major effect of metal exposure was the elimination of rare taxa (Fig. 2) . In the pristine soil, taxa with abundance values G10 5 cells per gram accounted for 99.9% of the diversity, and genetic diversity from this fraction of the community appears to have been purged by high metal pollution. The functional importance of these rare taxa for soil nutrient cycling and ecosystem resilience is unknown.
To assess the overall error for S t , we calculated the net impact of all error sources, including measurement error, Cot curve completeness, calibration rate, and hybridization of mismatched DNA (11) . The relatively minor effects of the first two factors were included in the error estimates for S t shown in Fig. 4 and could be reduced further ( fig. S3 ). Given that all error sources were random and uncorrelated, the total error for S t , calculated by standard propagation of errors (20) , was a factor of 8.2. As this error range affects S t but is not expected to influence the relative differences between the soils, we are confident of the relative impact of metal pollution.
Comparing the ability of numerous speciesabundance distributions to reproduce experimental DNA reassociation data showed that the soil bacterial communities were naturally best represented by the model-free approximation, followed closely by the zipf (i.e., power law) distribution. Hence, the original study substantially underestimated the species diversity of pristine soil bacterial communities. Moreover, heavy metal pollution reduced bacterial diversity not by a factor of 8, as previously suggested, but by a factor of about 1000, with rare species impacted the most. Although the minimum number of species in the soils can be estimated, the exact shape of the abundance distribution for rare species remains ambiguous and is an area for additional work. Overall, the improved analytical approach demonstrates that rigorous DNA reassociation studies can address otherwise intrac- SUMOylation-the covalent linking of small ubiquitin-related modifier protein (SUMO) to lysine residues-is a reversible posttranslational modification controlled by an enzymatic pathway analogous to the ubiquitin pathway (1-3). The addition of SUMO on target pro-teins has been implicated in transcriptional regulation by a number of mechanisms (3) (4) (5) (6) .
A hallmark of SUMOylation is that, for most substrates, only a small fraction of intracellular substrate molecules are modified at any given time. SUMO modification is rendered reversible by SUMO-specific proteases, such as the yeast ubiquitin-like protease type 1 (ULP1) or the mammalian sentrin-specific protease type 1 (SENP1) (7, 8) .
BMAL1 is a member of the basic helix-loophelix (bHLH)/Per-aryl hydrocarbon receptor nuclear transporter (ARNT)-Sim (PAS) domain family of transcription factors which, together with its heterodimerization partner CLOCK, drives the circadian clock mechanism (9) (10) (11) . Between the two PAS domains, which mediate CLOCK:BMAL1 dimerization (12) , there is a linker region of undetermined function. Some specific lysine residues in this region are well conserved across species and among different isoforms of the BMAL1 family (Fig. 1A) . Because lysines are targeted by multiple posttranslational modifications (13), we hypothesized that these residues could constitute regulatory sites. Computer modeling analysis has revealed that the best match for K 223 , K 229 , K 259 , and K 272 (14) in mouse BMAL1 (mBMAL1) corresponds to the SUMOylation consensus motif yKxE/D (3), where y is a hydrophobic residue and x may be any amino acid (Fig. 1A) . To (Fig. 1B) . When Myc-BMAL1 was coexpressed with His-tagged SUMO1 or a fusion protein containing green fluorescent protein and SUMO (GFP-SUMO1), we observed Myc-BMAL1 species of higher molecular weight, proportional to the size of additional SUMO modification. No modification of Myc-BMAL1 was observed by coexpressing His-SUMO1EG 97 YA 97 (G97A)^, a single-amino acid mutant that is unable to be transferred onto target substrates (15) . SUMOylation was further confirmed when immunoprecipitated Myc-BMAL1 reacted with antibodies to SUMO (Fig. 1C) . BMAL1 modification was enhanced upon coexpression of ubiquitin-like conjugating enzyme 9 (UBC9), a SUMO conjugating type enzyme (E2) ligase that activates the SUMOylation pathway (3). Conversely, coexpression of the SUMO1-specific protease SENP1 (8) reduced BMAL1 SUMOylation (Fig. 1D and fig. S1A ). Site-directed mutagenesis of the four consensus lysine residues in either Ala or Arg, alone or in combination, demonstrated that K 259 is the major in vivo SUMOylation site (Fig. 1, A and E, and fig.  S1B ) (16) . Importantly, K 259 is placed within the larger SUMO consensus motif RxxVKVExK (Fig. 1A) (17) . In vitro SUMOylation assays confirmed that BMAL1 is modified by SUMO1 specifically at the K 259 residue ( fig. S1C ). BMAL1 can also be modified by SUMO2 in vivo at the K 259 residue, comparable to modification by SUMO1 ( fig. S2) .
To establish the relevance of BMAL1 SUMOylation in circadian physiology, we analyzed the peripheral clock in the liver (10, 11, 18) . Liver tissues from mice entrained at different zeitgeber times (ZT) were collected and protein extracts were prepared in the presence or absence of N-ethylmaleimide (NEM), an inhibitor of SUMO proteases that stabilizes SUMO-modified proteins (19) (Fig. 2) . As previously reported (20, 21) , BMAL1 shows rhythmicity in protein abundance and phosphorylation, with hyperphosphorylated forms at ZT9 and at ZT15 and lower protein levels at ZT21 (Fig. 2A, top) . NEM stabilized a BMAL1 SUMOylated form (about 100 kD), the abundance of which oscillated in a circadian manner, with a peak at ZT9 (Fig. 2A,  middle) . No NEM-stabilized forms were detected at ZT15 and ZT21 ( fig. S3 ), whereas no SUMOylated BMAL1 was detected in the absence of NEM (Fig. 2A, lanes 5 to 8) . As a control, we examined the expression of the Period 1 (PER1) clock protein from the same extracts ( Fig. 2A, bottom) . We confirmed the identity of the 100-kD NEM-stabilized form by immunoprecipitation using an antibody to mBMAL1 (Fig. 2B) . The effect of NEM was verified by analyzing the levels of SUMOmodified RanGAP1 in the same extracts ( fig.  S4 ). The 100-kD SUMO-BMAL1 from liver extracts was readily cleaved by the SUMOspecific protease ULP1 (7), in a NEM-sensitive manner (Fig. 2C, lanes 4 and 5) . Similar results were obtained when the recombinant ULP1 used here was tested on SUMO-RanGAP1 ( fig.  S5 ). In vivo SUMOylation was confirmed when the immunoprecipitated 100-kD BMAL1 form reacted with an antibody to SUMO1 (Fig. 2D) . Finally, the rhythmic SUMOylation of BMAL1 is not likely due to oscillations in the Sumo genes ( fig. S6 ). These findings indicate that BMAL1 undergoes rhythmic SUMOylation in vivo, with a timing that parallels BMAL1 circadian activation.
BMAL1 heterodimerizes with the transcription factor CLOCK to induce the transcription of target genes (9) (10) (11) 22) . CLOCK also induces BMAL1 phosphorylation (23) by a yet unidentified mechanism. Here, we find that BMAL1 phosphorylation and SUMOylation increase in (fig. S7 ). This may indicate that the CLOCK:BMAL1 interaction could trigger phosphorylation and SUMOylation of BMAL1, events possibly coupled to circadian gene activation.
To investigate the role of CLOCK in the SUMOylation of BMAL1, Myc-BMAL1 or the Myc-BMAL1(K259R) mutant was coexpressed with increasing amounts of CLOCK. CLOCK induced BMAL1 SUMOylation in a dosedependent manner. The Myc-BMAL1(K259R) mutant was refractory to the effect elicited by CLOCK (Fig. 3A and fig. S9 ).
The presence of SUMO-BMAL1 in the liver from wild-type mice was compared with that in mice carrying mutations in Clock proteins (Fig. 3B and fig. S10 ). A number of factors contribute to the autoregulatory loops that constitute the clock mechanism (22, 24) . These include the products of the period genes, which are positively regulated by CLOCK:BMAL1 (25) , and the Cryptochrome genes Cry1 and Cry2, the products of which act as potent repressors (26) . Whereas neither the disruption of the Per1 gene (27) nor the combined mutation of the Cry1 and Cry2 genes (28) (Cry1 j/j /Cry2 j/j ) generated reduction in SUMO-BMAL1 levels, there was a notable effect on BMAL1 SUMOylation in Clock/Clock mice (29) . This effect was specific to BMAL1; there were no differences in the levels of SUMO-RanGAP1 in the same extracts (Fig.  3B, bottom) . Moreover, no SUMO-BMAL1 was detected in mouse embryo fibroblasts (MEFs) derived from Clock/Clock mice (Fig.  3C) , showing that the effect exerted by CLOCK is not restricted to the liver. SUMOylation of BMAL1 was rescued by transient expression of the wild-type Clock gene into MEFs from Clock/Clock mice (Fig. 3D, lane 3) , confirming that a functional CLOCK protein is essential for SUMO modification of BMAL1. Interestingly, because the mutant CLOCK protein present in Clock/Clock mice is still able to heterodimerize with BMAL1 and bind DNA (29) , SUMOylation may be an event downstream from transcriptional activation.
To determine the function of BMAL1 SUMOylation, we generated a retroviral expression system for Myc-BMAL1 or Myc-BMAL1(K259R) under the control of Bmal1 promoter. After infection, NIH3T3 cells were serum-shocked to analyze the rhythmic oscillation of BMAL1 expression. This approach recapitulates the circadian regulation of the clock in cell culture (30) . Whereas wild-type BMAL1 expression peaked at 20 hours after serum shock, with a second peak of lower amplitude at 44 hours, the Myc-BMAL1(K259R) mutant displayed no circadian oscillation (Fig. 4A) . These data support the notion that SUMO modification is required for BMAL1 rhythmicity. Whether under the regulation of the Bmal1 promoter or of a heterologous promoter, the Myc-BMAL1(K259R) protein was about twice as abundant as Myc-BMAL1 ( fig. S1B ), indicating that lack of SUMOylation may affect protein turnover. Protein half-life analysis by cycloheximide treatment experiments revealed that Myc-BMAL1(K259R) shows an average 50% increased stability compared with that of wild-type BMAL1 (Fig. 4B) . Unlike BMAL1, the decay curve of BMAL1(K259R) is not exponential, suggesting a complex degradation mechanism for a protein that is not SUMOylated.
To establish whether BMAL1 SUMOylation is involved in clock function, we undertook rescue experiments using MEFs generated from Bmal1 j/j mice (31) . These cells showed no BMAL1 expression (Fig. 4C, lane 1) , compared with MEFs generated from wild-type mice (lane 11). Bmal1 j/j MEFs were readily infected with the retrovirus vectors (Fig. 4A) , expressing either BMAL1 (Fig. 4C, lanes 2 to 4) or the BMAL1(K259R) mutant (Fig. 4C, lanes  8 to 10) . To study circadian rhythmicity, we scored for the serum shock-induced expression of endogenous dbp, an E-box controlled gene (30) . Although wild-type MEFs showed consistent dbp circadian oscillation, this was altered in Bmal1 j/j MEFs (Fig. 4D) . Infection of Bmal1 j/j MEFs with a virus expressing BMAL1 rescued circadian expression of dbp, whereas expression of the BMAL1(K259R) mutant protein generated a shorter period. This was likely due to an increased stability of a BMAL1 protein that cannot be SUMOylated, which in turn could influence the rhythmic expression of other clock proteins.
Our findings provide insight into the mechanisms that control the circadian levels of BMAL1 expression. Several mechanims could be proposed for such differences, including a direct interplay between SUMO modification and the yet unidentified BMAL1 degradation pathway or a SUMO-dependent interaction with partners that control BMAL1 stability (including CLOCK). SUMOylation of BMAL1 constitutes another level of control within the core circadian clock. Other clock proteins may undergo SUMOmodification in domains distinct from the PAS linker region. Unique elements of the SUMO pathway may be selective for the circadian clock machinery. The recent discovery and characterization of E3 SUMO ligases (3) may provide key tools to address these questions.
